Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.81 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.81 |
| ▸ | TSHR | P16473 | 2/20 | 0.81 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.81 |
| ▸ | PRKDC | P78527 | 2/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | ERN1 | O75460 | 6/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | HMGCR | P04035 | 1/20 | 0.50 |
| ▸ | TLR2 | O60603 | 1/20 | 0.48 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.48 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.48 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Asaraldehyde SCHEMBL29456596 | 0.90 | ALDH1A1 (1.00) | ALDH1A1KDM4ETSHRTDP1PRKDC | |
| Asaraldehyde SCHEMBL333451 | 0.90 | ALDH1A1 (1.00) | ALDH1A1KDM4ETSHRTDP1PRKDC | |
| SCHEMBL3136850 | 0.89 | ALDH1A1 (0.90) | ALDH1A1KDM4ETSHRTDP1PRKDC | |
| Asaraldehyde SCHEMBL27489564 | 0.87 | ALDH1A1 (0.95) | ALDH1A1KDM4ETSHRTDP1PRKDC | |
| SCHEMBL18232228 | 0.85 | ALDH1A1 (0.61) | ALDH1A1KDM4ETSHRTDP1PRKDC | |
| SCHEMBL1494078 | 0.85 | ALDH1A1 (0.68) | ALDH1A1KDM4ETSHRTDP1PRKDC | |
| SCHEMBL71268 | 0.84 | ALDH1A1 (0.65) | ALDH1A1KDM4ETSHRTDP1PRKDC | |
| SCHEMBL13537963 | 0.84 | ALDH1A1 (0.65) | ALDH1A1KDM4ETSHRTDP1PRKDC | |
| SCHEMBL1589608 | 0.84 | ALDH1A1 (0.65) | ALDH1A1KDM4ETSHRTDP1PRKDC | |
| SCHEMBL1570740 | 0.84 | ALDH1A1 (0.72) | ALDH1A1KDM4ETSHRTDP1PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1501471-B1 | USE OF ALPHA-DIALDEHYDES IN THE PRESENCE OF AN AMMONIUM SALT OF A BRÖNSTED ACID FOR DYEING KERATIN FIBRES | OREAL (FR) | 2006-06-07 | — | — | EP | claimed |
| US-20050273946-A1 | Use of alpha-dialdehydes in the presence of an ammonium salt of a bronsted acid for dyeing keratin fibres | L'OREAL S.A. (FR) | 2005-12-15 | — | — | US | claimed |
| EP-1501471-A1 | USE OF ALPHA-DIALDEHYDES IN THE PRESENCE OF AN AMMONIUM SALT OF A BRÖNSTED ACID FOR DYEING KERATIN FIBRES | L'OREAL (FR) | 2005-02-02 | — | — | EP | claimed |
| US-20040205905-A1 | Dye composition for keratin fibers, comprising at least one compound chosen from ortho- and alpha-dialdehyde compounds and at least one sulphur compound | L'OREAL S.A. (FR) | 2004-10-21 | — | — | US | claimed |
| EP-1430878-A1 | Composition to dye keratinic fibres comprising at least one ortho- or alpha-dialdehyde and at least one sulphurous compound | L'OREAL (FR) | 2004-06-23 | — | — | EP | claimed |
| WO-2003090701-A1 | USE OF α-DIALDEHYDES IN THE PRESENCE OF AN AMMONIUM SALT OF A BRÖNSTED ACID FOR DYEING KERATIN FIBRES | L'OREAL (FR) | 2003-11-06 | — | — | WO | claimed |
| US-20240400575-A1 | POLYCYCLIC COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS | UNIV BARCELONA (ES) | 2024-12-05 | — | — | US | disclosed |
| EP-3810572-B1 | POLYCYCLIC COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS | UNIV BARCELONA (ES) | 2023-11-15 | — | — | EP | disclosed |
| CN-112888674-B | Polycyclic compounds as soluble epoxide hydrolase inhibitors | 巴塞罗那大学 | 2023-06-30 | — | — | CN | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| CN-112888674-A | Polycyclic compounds as soluble epoxide hydrolase inhibitors | 巴塞罗那大学 | 2021-06-01 | — | — | CN | disclosed |
| US-11008282-B2 | Bicyclic-compounds for use as a medicament, in particular for treatment of parkinson's disease | KOESTER HUBERT (CH) | 2021-05-18 | — | — | US | disclosed |
| EP-3810572-A1 | POLYCYCLIC COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS | Universitat de Barcelona (ES) | 2021-04-28 | — | — | EP | disclosed |
| EP-1501471-B1 | USE OF ALPHA-DIALDEHYDES IN THE PRESENCE OF AN AMMONIUM SALT OF A BRÖNSTED ACID FOR DYEING KERATIN FIBRES | OREAL (FR) | 2006-06-07 | — | — | EP | disclosed |
| US-20050273946-A1 | Use of alpha-dialdehydes in the presence of an ammonium salt of a bronsted acid for dyeing keratin fibres | L'OREAL S.A. (FR) | 2005-12-15 | — | — | US | disclosed |
| EP-1501471-A1 | USE OF ALPHA-DIALDEHYDES IN THE PRESENCE OF AN AMMONIUM SALT OF A BRÖNSTED ACID FOR DYEING KERATIN FIBRES | L'OREAL (FR) | 2005-02-02 | — | — | EP | disclosed |
| US-20040205905-A1 | Dye composition for keratin fibers, comprising at least one compound chosen from ortho- and alpha-dialdehyde compounds and at least one sulphur compound | L'OREAL S.A. (FR) | 2004-10-21 | — | — | US | disclosed |
| EP-1430878-A1 | Composition to dye keratinic fibres comprising at least one ortho- or alpha-dialdehyde and at least one sulphurous compound | L'OREAL (FR) | 2004-06-23 | — | — | EP | disclosed |
| WO-2003090701-A1 | USE OF α-DIALDEHYDES IN THE PRESENCE OF AN AMMONIUM SALT OF A BRÖNSTED ACID FOR DYEING KERATIN FIBRES | L'OREAL (FR) | 2003-11-06 | — | — | WO | disclosed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050273946-A1 | Use of alpha-dialdehydes in the presence of an ammonium salt of a bronsted acid for dyeing keratin fibres | KRT18, PDIA5, CA6 | ALDH1A1 341/4885KDM4E 4170/4885TSHR 3743/4885 |
| US-20040205905-A1 | Dye composition for keratin fibers, comprising at least one compound chosen from ortho- and alpha-dialdehyde compounds and at least one sulphur compound | KRT18, DSP, DSG1 | ALDH1A1 50/4885KDM4E 1902/4885TSHR 4023/4885 |
| US-11008282-B2 | Bicyclic-compounds for use as a medicament, in particular for treatment of parkinson's disease | COMT, PNMT, DBH | ALDH1A1 576/4885KDM4E 2139/4885TSHR 1069/4885 |
| US-20240400575-A1 | POLYCYCLIC COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS | EPHX1, EPHX2, NCEH1 | ALDH1A1 81/4885KDM4E 2361/4885TSHR 4075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.